Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

5.44
BATS BZX Real-Time Price
As of 10:20am ET
 -0.18 / -3.20%
Today’s Change
4.39
Today|||52-Week Range
9.29
-5.72%
Year-to-Date
Stocks Under $10 Portfolio: Consumer Staples Overbought
Jan 22 / TheStreet.com - Paid Partner Content
TherapeuticsMD's Rejoice Study Data Published in Journal
Jan 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close5.62
Today’s open5.47
Day’s range5.43 - 5.49
Volume15,602
Average volume (3 months)2,900,334
Market cap$1.1B
Dividend yield--
Data as of 10:20am ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-36.11%
Earnings growth (this year)+5.25%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+34.05%
P/E ratioNM
Price/Sales89.15
Price/Book15.41

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...-0.69-10.76%
ALDRAlder Biopharmaceuti...-1.10-5.10%
DEPODepomed Inc-0.27-1.50%
RGENRepligen Corp+0.21+0.69%
Data as of 10:20am ET, 01/23/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$20.1M
Annual profit (last year)-$85.1M
Net profit margin-422.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts


Search for Jobs